Zentalis Share Price
NASDAQ: ZNTL | Micro Cap | HealthcareZentalis Stock Performance
Zentalis Share Price Today
As of 19 November 2026, Zentalis Pharmaceuticals, Inc.'s share price is $1.38. The stock opened at $1.50, compared to its previous close of $1.50. During today's trading session, Zentalis Pharmaceuticals, Inc.'s share price traded between $1.36 and $1.52, with an average price of $1.44. Over the past 52 weeks, the stock has recorded a high of $6.94 and a low of $1.28. In terms of performance, Zentalis Pharmaceuticals, Inc.'s share price has declined by 65.50% over the last six months and is down 3.50% on a year-on-year basis.
Zentalis Share Price Chart
Zentalis Quarterly Profit & Loss
All figures in USD
Zentalis Annual Profit & Loss
All figures in USD
Zentalis Balance Sheet
All figures in USD Million
Zentalis Cash Flow
All figures in USD Million
About Zentalis
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Zentalis Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.96 | $1.36 | -30.00% |
Oct 2026 | $2.74 | $1.95 | -29.22% |
Sep 2026 | $3.70 | $2.75 | -28.90% |
Aug 2026 | $4.66 | $3.88 | -18.16% |
Jul 2026 | $4.79 | $4.74 | -2.27% |
Jun 2026 | $3.99 | $4.84 | +21.12% |
May 2026 | $4.00 | $4.00 | -0.12% |
Apr 2026 | $2.43 | $4.00 | +70.43% |
Mar 2026 | $2.44 | $2.35 | -1.67% |
Feb 2026 | $2.42 | $2.39 | -2.05% |
Jan 2026 | $1.33 | $2.44 | +81.41% |
Dec 2025 | $1.39 | $1.34 | -5.94% |